clarus ventures

49
Helpful Tips for the Aspiring Entrepreneur - A Venture Capital Perspective Emmett Cunningham M.D., Ph.D., M.P.H. Partner, Clarus Ventures, LLC www.clarusventures.com

Upload: healthegy

Post on 13-Apr-2017

175 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: Clarus Ventures

Helpful Tips for the

Aspiring Entrepreneur -

A Venture Capital

Perspective

Emmett Cunningham M.D., Ph.D., M.P.H.

Partner, Clarus Ventures, LLC

www.clarusventures.com

Page 2: Clarus Ventures

McCormick Place, Chicago

Spotlight on Innovation in Ophthalmology

From Theory to Therapy

Monday, October 20th, 2014

12:15PM - 1:45PM

GRAND BALLROOM S100C

Page 3: Clarus Ventures

Protect Your Ideas (IP)

Is it still intellectual

property theft if the

ideas aren’t intellectual?

• Draft a dated / signed invention disclosure

• File with counsel / tech transfer office

Page 4: Clarus Ventures

File Before You Publish or Present

“Prior art” is no longer patentable

Page 5: Clarus Ventures

Choose Your Advisors Carefully

• Discrete

• Knowledgeable

• Experienced

• Counsel

• Consultants

• Institutional

Investors

CDA

Page 6: Clarus Ventures

Core

Team

Page 7: Clarus Ventures

Understand the Difference

Between a Company and a Product

Tools

Instruments

Small market devices

Small market drugs

Multiple products

Large markets

Product Company

Page 8: Clarus Ventures

Understand What it Takes to Bring Tools,

Devices, and Drugs to Market

Tools

Instruments

510(k) Devices PMA Devices

Drugs

< $500K

1 year

$5-50M

3 - 5 years

$50-200M

5-10 years

Ophthalmics

Individuals TeamsNon-Ophthalmic drugs can cost over $1 billion

Page 9: Clarus Ventures

Think Through What Role You

Want to Take in the Process

Page 10: Clarus Ventures

Know Your Own

Desires and Limitations

Page 11: Clarus Ventures

Set Realistic Expectations

Regarding Valuation

“A small piece of a big pie

is much better than a big

piece of nothing ……”

Page 12: Clarus Ventures

Money is Only Part of the Reward…..

The primary

objectives are to

see your idea

become a reality &

help patients …

Page 13: Clarus Ventures

MoneyThe Most Expensive Thing You Will Ever Buy

Page 14: Clarus Ventures

Understand Funding Sources

Stage

Source

Of Funds

Funds

Required

Availability

Of Funds

Modified after: Center for Venture Research – University of New Hampshire

Pre-Seed Seed / Startup Early Late

Founders

Friends

Family

SBIR / Foundations

Angels / IncubatorsInstitutional Investors (VC)

$50K $100K $1M $100M

Risk

Risk Not drawn to scale!

“Innovation Gap”

High

Low

Page 15: Clarus Ventures

$651$665 $660 $666

$670

$688$706 $701

$702

$656

$674 $675

$820$810

$779$764

$740

$763$770

$741

$727

$670

$500

$550

$600

$650

$700

$750

$800

$850

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015E

NEI (Actual) NEI (2014$)

NEI Funding Flat, but …

Down ~25% after Inflation (2014$)

28% of RO1s Funded

Inflation Calculator

http://data.bls.gov/cgi-bin/cpicalc.pl

Data provided by :

Matthew McMahon, Ph.D.

Director, Office of Translational

Research, NEI

$0

Page 16: Clarus Ventures

Founders, Friends, and Family

(Typically < $500K)

“Yes, that is me.

We’re a very new company.”

“You’ll never guess who

I bumped into today…”

Founders

Family

Friends

Page 18: Clarus Ventures

Angel Investors

(Typically < $2M)

Ask local entrepreneurs, lawyers, etc…..https://www.cbinsights.com/blog/top-angel-groups-mosaic/

Top 20

Healthcare

Angel Groups

Page 19: Clarus Ventures

Angel Investors

(Typically < $2M)

https://www.cbinsights.com/blog/healthcare-periodic-table/

• Launchpad Venture Group

• Central Texas Angel Network

• Houston Angel Network

• Keiretsu Forum

• Maine Angels

• Sand Hill Angels

• Life Science Angels

• Tech Coast Angels

• BlueTree Allied Angels

• Queen City Angels

• Desert Angels

• Golden Seeds

#1

www.angelcapitalassociation.org

Ask local entrepreneurs, lawyers, etc…..

Page 20: Clarus Ventures

Incubators & Accelerators

(Various Models - Typically < $2M)

www.forsightlabs.com

And many universities…..

http://www.jnjinnovation.com/

http://www.roche.com/research_and_development/partnering.htm

Ycombinator

www.ycombinator.com

http://startx.stanford.edu/

Page 21: Clarus Ventures

Innovation Gap Widening

Stage

Source

Of Funds

Funds

Required

Availability

Of Funds

Modified after: Center for Venture Research – University of New Hampshire

Pre-Seed Seed / Startup Early Late

Founders

Friends

Family

SBIR / Foundations

Angels / IncubatorsInstitutional Investors (VC)

$50K $100K $1M $100M

Risk

Risk Not drawn to scale!

“Innovation Gap”

High

Low

Page 22: Clarus Ventures

Venture Capitalists

(Typically > $5M)

Page 23: Clarus Ventures

Venture Capitalists

(Typically > $5M)

www.nvca.org

https://www.cbinsights.com/blog/healthcare-periodic-table/

Page 24: Clarus Ventures

Source: PricewaterhouseCoopers, Silicon Valley Bank

Total VC vs BioPharma vs

Medical Device Investments (2000-2013)

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

20%

$-

$10

$20

$30

$40

$50

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Billio

ns

Total VC $ BioPharma Device

$99 Bn Healthcare ~ $4Bn

Courtesy Jon Norris, SVB

Page 25: Clarus Ventures

Lifescience Venture Capital Funding Gap

$6.0

$7.3

$9.1

$8.6

$6.6 $6.3

$7.7

$6.7

$6.7

$3.4

$…

$7.9

$6.1

$5.2

$1.8

$3.7 $3.6

$3.9

$0.0

$1.0

$2.0

$3.0

$4.0

$5.0

$6.0

$7.0

$8.0

$9.0

$10.0

2005 2006 2007 2008 2009 2010 2011 2012 2013

Invested ($Bn)Fundraised ($Bn)

Source: PricewaterhouseCoopers, Silicon Valley Bank Courtesy Jon Norris, SVB

$2.8 Bn

(1.7x Gap)

Page 26: Clarus Ventures

0

100

200

300

400

500

600

0

5

10

15

20

25

30

To

tal D

olla

rs In

ve

ste

d ($

M)

Nu

mb

er

of

Ve

ntu

re D

ea

ls f

or

Dru

g a

nd

De

vic

e

# Rx Deals # Device Deals VC Investment ($USD, Millions)

business intelligence

Ophthalmic Investments by VCs Over Time

(1999 – 2014*)

VC Funding Stable• ~ $400M / year

• 15 – 20 deals

*2014 figures through September

SOURCE: Strategic Transactions

Page 27: Clarus Ventures

VC Investment By Ophthalmic Indication

(1999-2014*)

4…

36

2118

12 118 7

12

7

3 4

0

5

10

15

20

25

30

35

40

45

50

0

100

200

300

400

500

600

700

800

900

1,000

1,100

1,200

Nu

mb

er o

f De

als

Pri

va

te P

lac

em

en

ts (

$M

)

Dollars ($ Millions) Number of deals

*2014 figures through September

SOURCE: Strategic Transactions

Page 28: Clarus Ventures
Page 29: Clarus Ventures

50%

100%

150%

200%

250%

300%

350%

400%

450%

2004 2006 2008 2010 2012 2014

10-year Stock Price Performance

53%

292%

Source: FactSet as of 09/16/141 Medtech index consists of medical technology companies traded on North American exchanges with market capitalizations over $1bn

78%

Returns summary

10 yr 5 yr YTD

Medtech1

63%

Biotech

235%

S&P 500

87%

16%

19%

9%

Best Three Years for Biotech in a

Decade

Page 30: Clarus Ventures
Page 32: Clarus Ventures

Give Yourself Enough Time To

Raise Money – Up to12 months…

Page 33: Clarus Ventures

Ask for Enough to Get to an

Important Milestone (Data) …Plus

…time to raise more

money….

Page 34: Clarus Ventures

Seek Out Experienced Investors

“Your financial goal is to break even?

You must be an experienced investor!

Page 35: Clarus Ventures

Come to Pitch Meetings

Practiced and Prepared

He’s Expecting you………..

Page 36: Clarus Ventures

Take the Time to Write a

Concise Business Plan

• Consolidate your ideas

• Understand the strengths and weaknesses of the opportunity

• Learn the market dynamics

• Construct a realistic budget and timeline

• Use of Proceeds ; Milestones

Page 37: Clarus Ventures

Focus on Business Model and

Confidence in Rationale – Science and Data

Clinical Results

Page 38: Clarus Ventures

It’s All About the

PowerPoint Presentation

Use Pictures and Graphics

Page 39: Clarus Ventures

And not this . . .

Page 40: Clarus Ventures

Word Slides Are a Sleeping Pill

Page 41: Clarus Ventures

Our Brains are Compartmentalized

Very

Difficult to

Listen and

Read at the

Same Time

Page 42: Clarus Ventures

Average Attention Span ~ 10 minutesSegment Presentation Into Separate Topics / Q & A

10 minutesNew Topic or Q & A

Page 43: Clarus Ventures

Believe in Yourself …

Innovation

is driven by

individuals

and small

teams

Page 44: Clarus Ventures

And in your vision …

Steve Jobs

“People don’t

know what

they want until

I show it to

them.”

Page 45: Clarus Ventures

Follow Your Bliss……..Not Others

Page 46: Clarus Ventures

You Don’t Always Have to Leave

Your Day Job…..

Page 47: Clarus Ventures

And have fun . . .

Page 48: Clarus Ventures

Plan to Join Us . . .

7th Annual OIS@AAO

Las Vegas, Nevada

November 12th, 2015

4rd Annual OIS@ASCRS

San Diego, California

April 16th, 2015

www.ois.net

Page 49: Clarus Ventures

[email protected]

650 238 5014

www.clarusventures.com